OCEAOcean Biomedical Inc. Common Stock
0.0018USD+125.00%Mkt Cap: 418257 $P/E: —4d ago
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidat…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap418.26K $
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.48M $
Revenue/Share—
Last Price0.0018 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-0.91
EPS (Forward)-0.89
52W Range
0.000012% of range0.0145
52W High0.0145 USD
52W Low0.0000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE9.71%
ROA-1051.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.18M $
CapEx (TTM)—
FCF Margin—
FCF Yield-1277.83%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.17
Current Ratio0.06
Quick Ratio—
Book Value/Sh-0.5570 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.232.37M
Float208.41M
Insiders10.31%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float2.05%
Short % Out.1.77%
Shares Short2.93M
Short (prev mo.)5.72M
Technical
SMA 500.0004 (+373.7%)
SMA 2000.0006 (+178.0%)
Beta-0.52
S&P 52W Chg18.16%
Avg Vol (30d)79.06K
Avg Vol (10d)159.56K
Technical Indicators
RSI (14)67.6
MACD0.0002
MACD Signal0.0001
MACD Hist.+0.0001
BB Upper0.0014 USD
BB Middle0.0006 USD
BB Lower-0.0003 USD
BB Width313.84%
ATR (14)0.0008 USD
Vol Ratio (20d)0.05x